StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Creeping takeover

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Mar 01, 2023 2:15pm

84 Views

Post# 35313100

RE:RE:RE:Creeping takeover

I like what Tripp said in the Q&A in the presentation Tyler posted. They are basically cash flow positive and these draws are for marketing/advancing the business forward. With agreements already in place. This $25 million war chest is for new business so go for it.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec